WEBSITE BSE:543252 NSE: FAIRCHEMOR Inc. Year: 2019 Industry: Chemicals My Bucket: Add Stock
Last updated: 15:56
No Notes Added Yet
1. Business Overview
Fairchem Organics Ltd. is an India-based manufacturer of specialty chemicals. The company primarily focuses on oleo chemicals and their derivatives, utilizing various vegetable oils as key raw materials. Its product portfolio includes refined glycerine, fatty acids, dimer acid, and other specialty intermediates. Fairchem operates on a B2B model, supplying its products to a diverse range of industries such as paints and coatings, polymers, adhesives, printing inks, personal care, nutrition, pharmaceuticals, and other industrial applications. Revenue is generated through the manufacturing and sale of these value-added chemical products.
2. Key Segments / Revenue Mix
While Fairchem Organics Ltd. does not typically report formal business segments with specific revenue breakdowns, its operations can be broadly categorized by its primary product groups:
Oleo Chemicals: This forms the core, including refined glycerine, fatty acids, and their various derivatives.
Dimer Acid: A key specialty chemical product.
Other Specialty Chemicals & Intermediates: A range of other chemicals catering to diverse industrial applications.
The company's focus is predominantly on value-added products derived from natural, renewable vegetable oils.
3. Industry & Positioning
Fairchem Organics operates within the Indian specialty chemicals industry, a sector characterized by high growth, diverse applications, and increasing global demand. This industry benefits from factors such as import substitution, robust domestic consumption, and a strong push for exports. Within this broader landscape, Fairchem is positioned as a specialized player in the oleo chemicals segment, known for its process expertise in converting vegetable oils into functional and value-added chemical products. It competes with both domestic and international manufacturers in various niche areas.
4. Competitive Advantage (Moat)
Fairchem Organics possesses several competitive advantages:
Process Expertise & R&D: The company has developed specialized knowledge and proprietary processes for the complex conversion of vegetable oils into high-purity specialty chemicals, leading to efficient yields and product quality.
Backward Integration/Sourcing: Potential for established relationships and capabilities in sourcing diverse vegetable oil feedstocks, ensuring consistent supply and quality control.
Customer Relationships: Long-standing relationships with industrial customers across multiple end-user industries, built on product reliability and customization capabilities.
Diversified Product Applications: While focused on oleo-chemicals, the wide range of derivatives and their applications across various sectors mitigates dependence on any single industry.
5. Growth Drivers
Rising Demand for Specialty Chemicals: Continued global and domestic growth in demand for specialty chemicals, particularly bio-based and eco-friendly options.
End-User Industry Growth: Expansion in key client industries such as paints, coatings, polymers, personal care, and pharmaceuticals will drive demand for Fairchem's products.
Capacity Expansion: Any ongoing or planned capital expenditure projects to enhance manufacturing capacity will facilitate higher production volumes and sales.
New Product Development: Introduction of new value-added derivatives or diversification into adjacent specialty chemical niches.
Export Opportunities: Leveraging competitive manufacturing capabilities to cater to increasing international demand for specialty chemicals.
6. Risks
Raw Material Price Volatility: Significant dependence on vegetable oils means profitability is highly susceptible to fluctuations in global edible oil prices.
Intense Competition: The specialty chemicals market is competitive, potentially leading to pricing pressures and margin erosion.
Regulatory & Environmental Compliance: Strict and evolving environmental regulations, as well as chemical safety standards, can incur significant compliance costs and operational restrictions.
Economic Downturn: A slowdown in global or domestic economic activity could reduce demand from key end-user industries.
Foreign Exchange Fluctuations: Exposure to currency volatility due to potential imports of raw materials and exports of finished goods.
7. Management & Ownership
Fairchem Organics Ltd. is promoted by the V.G. Jatiya Group. The management team typically consists of professionals with considerable experience in the chemicals sector, particularly in oleo chemicals. The promoter group holds a significant stake in the company, reflecting a strong alignment of interests. The remaining ownership is distributed among institutional investors (Domestic and Foreign) and the public.
8. Outlook
Fairchem Organics operates in an attractive segment of the specialty chemicals industry, poised to benefit from increasing demand for bio-based and value-added oleo chemicals. Its core strengths lie in its process expertise, diversified product applications, and established customer relationships. Anticipated growth in end-user industries and potential capacity expansions are positive drivers. However, the company faces inherent challenges, notably the volatility of raw material prices and intense competition, which can impact its profitability and market share. Navigating these risks through efficient raw material procurement, continuous innovation, and strategic capacity utilization will be crucial for the company's sustained performance and ability to capitalize on industry growth trends.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹773 Cr.
Stock P/E 35.2
P/B 2.9
Current Price ₹614
Book Value ₹ 208.8
Face Value 10
52W High ₹1100
Dividend Yield 0.16%
52W Low ₹ 427.9
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 148 | 161 | 165 | 139 | 114 | 121 | 131 | 112 | 100 | 117 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Total Income | 148 | 161 | 165 | 139 | 114 | 121 | 131 | 112 | 100 | 117 |
| Total Expenditure | 128 | 142 | 143 | 130 | 106 | 116 | 126 | 107 | 96 | 109 |
| Operating Profit | 20 | 19 | 22 | 9 | 8 | 5 | 5 | 5 | 4 | 9 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Profit Before Tax | 17 | 16 | 19 | 5 | 5 | 1 | 2 | 1 | -0 | 5 |
| Provision for Tax | 4 | 4 | 5 | 1 | 1 | 1 | 0 | 0 | -0 | 1 |
| Profit After Tax | 12 | 12 | 14 | 4 | 4 | 1 | 1 | 1 | -0 | 4 |
| Adjustments | 0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | -0 |
| Profit After Adjustments | 12 | 12 | 14 | 4 | 4 | 1 | 1 | 1 | -0 | 4 |
| Adjusted Earnings Per Share | 9.5 | 9 | 10.6 | 3.1 | 2.7 | 0.5 | 0.9 | 0.6 | -0.1 | 2.9 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 306 | 397 | 643 | 648 | 621 | 538 | 460 |
| Other Income | 7 | 0 | 0 | 1 | 1 | 1 | 1 |
| Total Income | 313 | 397 | 644 | 649 | 623 | 539 | 460 |
| Total Expenditure | 258 | 328 | 538 | 576 | 554 | 495 | 438 |
| Operating Profit | 55 | 69 | 105 | 73 | 68 | 44 | 23 |
| Interest | 7 | 7 | 7 | 6 | 4 | 4 | 4 |
| Depreciation | 6 | 7 | 7 | 8 | 9 | 11 | 12 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Profit Before Tax | 42 | 56 | 91 | 59 | 55 | 30 | 8 |
| Provision for Tax | 8 | 13 | 23 | 15 | 14 | 8 | 1 |
| Profit After Tax | 35 | 42 | 68 | 44 | 41 | 22 | 6 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 35 | 42 | 68 | 44 | 41 | 22 | 6 |
| Adjusted Earnings Per Share | 0 | 32.6 | 52.2 | 33.4 | 31.1 | 16.9 | 4.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -13% | -6% | 12% | 0% |
| Operating Profit CAGR | -35% | -25% | -4% | 0% |
| PAT CAGR | -46% | -31% | -9% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -25% | -19% | -6% | NA% |
| ROE Average | 7% | 13% | 21% | 22% |
| ROCE Average | 10% | 17% | 24% | 24% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 127 | 169 | 232 | 259 | 290 | 302 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 16 | 26 | 10 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 13 | 13 | 15 | 16 | 18 | 21 |
| Total Current Liabilities | 63 | 51 | 67 | 67 | 26 | 79 |
| Total Liabilities | 219 | 259 | 324 | 342 | 334 | 402 |
| Fixed Assets | 126 | 126 | 141 | 156 | 191 | 201 |
| Other Non-Current Assets | 18 | 34 | 46 | 38 | 10 | 20 |
| Total Current Assets | 75 | 98 | 137 | 149 | 133 | 181 |
| Total Assets | 219 | 259 | 324 | 342 | 334 | 402 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | 31 | 40 | 40 | 50 | 74 | -17 |
| Cash Flow from Investing Activities | -24 | -23 | -34 | -14 | -18 | -26 |
| Cash Flow from Financing Activities | -7 | -17 | -6 | -35 | -57 | 42 |
| Net Cash Inflow / Outflow | 0 | -0 | -0 | -0 | 0 | -0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 32.63 | 52.15 | 33.41 | 31.1 | 16.88 |
| CEPS(Rs) | 0 | 37.68 | 57.63 | 39.67 | 38.23 | 24.97 |
| DPS(Rs) | 0 | 3.5 | 13 | 7.5 | 7.5 | 7.5 |
| Book NAV/Share(Rs) | 0 | 129.59 | 178.29 | 199.11 | 222.67 | 231.96 |
| Core EBITDA Margin(%) | 15.78 | 17.36 | 16.3 | 11.04 | 10.67 | 7.88 |
| EBIT Margin(%) | 15.99 | 15.77 | 15.25 | 9.9 | 9.37 | 6.19 |
| Pre Tax Margin(%) | 13.84 | 14.01 | 14.19 | 8.95 | 8.7 | 5.51 |
| PAT Margin (%) | 11.32 | 10.71 | 10.56 | 6.64 | 6.45 | 4.05 |
| Cash Profit Margin (%) | 13.27 | 12.37 | 11.67 | 7.89 | 7.93 | 5.99 |
| ROA(%) | 15.86 | 17.8 | 23.31 | 13.05 | 11.97 | 5.97 |
| ROE(%) | 30.52 | 30.08 | 33.88 | 17.7 | 14.75 | 7.42 |
| ROCE(%) | 25.34 | 29.86 | 37.75 | 21.49 | 19.4 | 10.14 |
| Receivable days | 45.11 | 38.95 | 30.92 | 34.77 | 34.72 | 48.07 |
| Inventory Days | 41.97 | 37.06 | 32.72 | 41.79 | 43.52 | 53.13 |
| Payable days | 11.78 | 12.2 | 8.14 | 7.53 | 9.66 | 10.55 |
| PER(x) | 0 | 22.94 | 28.85 | 27.36 | 38.16 | 51.93 |
| Price/Book(x) | 0 | 5.78 | 8.44 | 4.59 | 5.33 | 3.78 |
| Dividend Yield(%) | 0 | 0.47 | 0.86 | 0.82 | 0.63 | 0.86 |
| EV/Net Sales(x) | 0 | 2.6 | 3.14 | 1.91 | 2.5 | 2.24 |
| EV/Core EBITDA(x) | 0 | 14.92 | 19.21 | 16.99 | 22.8 | 27.27 |
| Net Sales Growth(%) | 0 | 29.39 | 62.19 | 0.76 | -4.1 | -13.45 |
| EBIT Growth(%) | 0 | 27.64 | 56.86 | -33.89 | -9.28 | -42.91 |
| PAT Growth(%) | 0 | 22.42 | 59.84 | -35.94 | -6.9 | -45.74 |
| EPS Growth(%) | 0 | 0 | 59.84 | -35.94 | -6.9 | -45.74 |
| Debt/Equity(x) | 0.59 | 0.34 | 0.27 | 0.19 | 0.03 | 0.21 |
| Current Ratio(x) | 1.19 | 1.93 | 2.04 | 2.23 | 5.1 | 2.3 |
| Quick Ratio(x) | 0.63 | 1.03 | 1 | 1.03 | 2.42 | 1.17 |
| Interest Cover(x) | 7.45 | 8.96 | 14.31 | 10.36 | 13.88 | 9.16 |
| Total Debt/Mcap(x) | 0 | 0.06 | 0.03 | 0.04 | 0 | 0.06 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 58.88 | 58.88 | 58.7 | 58.7 | 61.19 | 61.19 | 61.19 | 61.19 | 61.19 | 63.26 |
| FII | 6.22 | 6.29 | 6.29 | 6.36 | 6.31 | 6.31 | 6.28 | 6.18 | 6.34 | 6.35 |
| DII | 5.28 | 5.26 | 5.16 | 5.16 | 5.16 | 5.58 | 5.66 | 5.66 | 2.01 | 2.06 |
| Public | 29.62 | 29.56 | 29.84 | 29.77 | 27.34 | 26.91 | 26.87 | 26.97 | 30.45 | 28.34 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.77 | 0.77 | 0.76 | 0.76 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
| FII | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| DII | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.03 | 0.03 |
| Public | 0.39 | 0.38 | 0.39 | 0.39 | 0.36 | 0.35 | 0.35 | 0.35 | 0.4 | 0.36 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.26 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.